MSK is the first hospital in New York City to offer gene therapy through its pediatric cancer program MSK Kids. Exagamglogene autotemcel (exa-cel) (Casgevy®) is a gene therapy for treating sickle cell ...

Hinge Health, which just went public last month, launched a referral network of in-person providers to complement its virtual ...

Hinge Health received widespread bullish initiation coverage on Monday from a dozen brokerages, with analysts highlighting ...

Analysts initiate coverage of Hinge Health with Buy ratings, citing strong tech, recurring revenue, and a growing $18.5 ...

According to a recent report by Coherent Market Insights, the global Digital Musculoskeletal (MSK) Care Market is estimated ...

Truist said Hinge has posted a 45% compound annual growth rate in billings and 55% in revenue from 2022 to 2024, supported by ...

"City of Hope and MSK develop tool to predict CAR T therapy outcomes for NHL" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site ...

A stem cell–based therapy initially developed at Memorial Sloan Kettering Cancer Center (MSK) may lead to a new treatment for advanced Parkinson's disease, according to results from a phase 1 ...

including guided physical therapy and educational and behavioural support. Chief executive Daniel Perez told Bloomberg that 20 million Americans now have access to Hinge Health to help the MSK ...

In 2022, MSK researchers found strong evidence in animal ... The findings suggest APOBEC3 mutagenesis as a key factor in therapy resistance and a potential therapeutic target.